Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.414
https://www.valueinhealthjournal.com/article/S1098-3015(17)30748-9/fulltext
Title :
Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30748-9&doi=10.1016/j.jval.2017.08.414
First page :
A471
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
389